HARBOR CAPITAL ADVISORS, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
HARBOR CAPITAL ADVISORS, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$235,967
+8.6%
73,510
+7.3%
0.04%
-2.2%
Q3 2023$217,205
-24.7%
68,519
+18.0%
0.05%
-20.7%
Q2 2023$288,489
+10.7%
58,046
+10.0%
0.06%
-22.7%
Q1 2023$260,625
-0.9%
52,758
+26.2%
0.08%
-70.6%
Q4 2022$262,928
-60.3%
41,801
-31.8%
0.26%
-58.1%
Q3 2022$662,000
-35.5%
61,294
-31.9%
0.61%
-22.2%
Q2 2022$1,026,000
+21.4%
89,992
-3.0%
0.78%
+96.2%
Q1 2022$845,000
-52.6%
92,755
-22.4%
0.40%
-38.7%
Q4 2021$1,784,000119,5470.65%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders